nodes	percent_of_prediction	percent_of_DWPC	metapath
Epirubicin—UGT2B7—Mycophenolate mofetil—systemic lupus erythematosus	0.208	0.548	CbGbCtD
Epirubicin—ABCC1—Cyclosporine—systemic lupus erythematosus	0.112	0.295	CbGbCtD
Epirubicin—ABCC1—Methotrexate—systemic lupus erythematosus	0.0593	0.156	CbGbCtD
Epirubicin—YWHAG—blood plasma—systemic lupus erythematosus	0.00646	0.0497	CbGeAlD
Epirubicin—CHD1—nephron tubule—systemic lupus erythematosus	0.00539	0.0414	CbGeAlD
Epirubicin—PLA2G4A—blood plasma—systemic lupus erythematosus	0.00482	0.037	CbGeAlD
Epirubicin—CHD1—cortex of kidney—systemic lupus erythematosus	0.00461	0.0354	CbGeAlD
Epirubicin—CHD1—lymphoid tissue—systemic lupus erythematosus	0.00407	0.0312	CbGeAlD
Epirubicin—CHD1—tendon—systemic lupus erythematosus	0.00382	0.0294	CbGeAlD
Epirubicin—AURKA—kidney—systemic lupus erythematosus	0.00382	0.0293	CbGeAlD
Epirubicin—CHD1—bone marrow—systemic lupus erythematosus	0.0037	0.0284	CbGeAlD
Epirubicin—DHCR7—nephron tubule—systemic lupus erythematosus	0.00363	0.0279	CbGeAlD
Epirubicin—AURKA—Mycophenolic acid—Mycophenolate mofetil—systemic lupus erythematosus	0.00362	0.474	CbGdCrCtD
Epirubicin—YWHAG—connective tissue—systemic lupus erythematosus	0.00344	0.0264	CbGeAlD
Epirubicin—DHCR7—skin of body—systemic lupus erythematosus	0.00339	0.026	CbGeAlD
Epirubicin—CHD1—lung—systemic lupus erythematosus	0.00336	0.0258	CbGeAlD
Epirubicin—AURKA—lymphoid tissue—systemic lupus erythematosus	0.00328	0.0252	CbGeAlD
Epirubicin—DHCR7—cortex of kidney—systemic lupus erythematosus	0.00311	0.0239	CbGeAlD
Epirubicin—CHD1—nervous system—systemic lupus erythematosus	0.00311	0.0239	CbGeAlD
Epirubicin—AURKA—tendon—systemic lupus erythematosus	0.00308	0.0237	CbGeAlD
Epirubicin—CHD1—central nervous system—systemic lupus erythematosus	0.00299	0.023	CbGeAlD
Epirubicin—AURKA—bone marrow—systemic lupus erythematosus	0.00299	0.0229	CbGeAlD
Epirubicin—YWHAG—kidney—systemic lupus erythematosus	0.00293	0.0225	CbGeAlD
Epirubicin—YWHAG—cortex of kidney—systemic lupus erythematosus	0.00285	0.0219	CbGeAlD
Epirubicin—DHCR7—lymphoid tissue—systemic lupus erythematosus	0.00274	0.0211	CbGeAlD
Epirubicin—AURKA—lung—systemic lupus erythematosus	0.00271	0.0208	CbGeAlD
Epirubicin—UGT2B7—kidney—systemic lupus erythematosus	0.00265	0.0203	CbGeAlD
Epirubicin—PLA2G4A—connective tissue—systemic lupus erythematosus	0.00257	0.0197	CbGeAlD
Epirubicin—YWHAG—lymphoid tissue—systemic lupus erythematosus	0.00252	0.0193	CbGeAlD
Epirubicin—AURKA—nervous system—systemic lupus erythematosus	0.0025	0.0192	CbGeAlD
Epirubicin—DHCR7—bone marrow—systemic lupus erythematosus	0.0025	0.0192	CbGeAlD
Epirubicin—AURKA—central nervous system—systemic lupus erythematosus	0.00241	0.0185	CbGeAlD
Epirubicin—YWHAG—tendon—systemic lupus erythematosus	0.00237	0.0182	CbGeAlD
Epirubicin—YWHAG—bone marrow—systemic lupus erythematosus	0.00229	0.0176	CbGeAlD
Epirubicin—DHCR7—lung—systemic lupus erythematosus	0.00226	0.0174	CbGeAlD
Epirubicin—PLA2G4A—cortex of kidney—systemic lupus erythematosus	0.00213	0.0164	CbGeAlD
Epirubicin—DHCR7—nervous system—systemic lupus erythematosus	0.0021	0.0161	CbGeAlD
Epirubicin—YWHAG—lung—systemic lupus erythematosus	0.00208	0.0159	CbGeAlD
Epirubicin—DHCR7—central nervous system—systemic lupus erythematosus	0.00202	0.0155	CbGeAlD
Epirubicin—Doxorubicin—NOS3—systemic lupus erythematosus	0.00199	1	CrCbGaD
Epirubicin—YWHAG—nervous system—systemic lupus erythematosus	0.00192	0.0148	CbGeAlD
Epirubicin—YWHAG—central nervous system—systemic lupus erythematosus	0.00185	0.0142	CbGeAlD
Epirubicin—PLA2G4A—tendon—systemic lupus erythematosus	0.00176	0.0136	CbGeAlD
Epirubicin—PLA2G4A—Raltitrexed—Methotrexate—systemic lupus erythematosus	0.00174	0.228	CbGdCrCtD
Epirubicin—PLA2G4A—bone marrow—systemic lupus erythematosus	0.00171	0.0131	CbGeAlD
Epirubicin—TOP2A—tendon—systemic lupus erythematosus	0.00168	0.0129	CbGeAlD
Epirubicin—TOP2A—bone marrow—systemic lupus erythematosus	0.00162	0.0125	CbGeAlD
Epirubicin—PLA2G4A—lung—systemic lupus erythematosus	0.00155	0.0119	CbGeAlD
Epirubicin—TOP2A—lung—systemic lupus erythematosus	0.00147	0.0113	CbGeAlD
Epirubicin—PLA2G4A—nervous system—systemic lupus erythematosus	0.00143	0.011	CbGeAlD
Epirubicin—PLA2G4A—central nervous system—systemic lupus erythematosus	0.00138	0.0106	CbGeAlD
Epirubicin—ABCC1—cortex of kidney—systemic lupus erythematosus	0.00122	0.00935	CbGeAlD
Epirubicin—ABCC1—tendon—systemic lupus erythematosus	0.00101	0.00775	CbGeAlD
Epirubicin—ABCC1—lung—systemic lupus erythematosus	0.000886	0.0068	CbGeAlD
Epirubicin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—VDR—systemic lupus erythematosus	0.000536	0.00885	CbGpPWpGaD
Epirubicin—YWHAG—PDGFR-beta signaling pathway—BLK—systemic lupus erythematosus	0.000535	0.00884	CbGpPWpGaD
Epirubicin—AURKA—Integrated Breast Cancer Pathway—GADD45A—systemic lupus erythematosus	0.000531	0.00877	CbGpPWpGaD
Epirubicin—YWHAG—Class I PI3K signaling events mediated by Akt—CDKN1B—systemic lupus erythematosus	0.000504	0.00832	CbGpPWpGaD
Epirubicin—PLA2G4A—PDGF Pathway—JAK1—systemic lupus erythematosus	0.0005	0.00826	CbGpPWpGaD
Epirubicin—YWHAG—Class I PI3K signaling events mediated by Akt—CDKN1A—systemic lupus erythematosus	0.000465	0.00768	CbGpPWpGaD
Epirubicin—ABCC1—S1P1 pathway—PTGS2—systemic lupus erythematosus	0.00042	0.00693	CbGpPWpGaD
Epirubicin—TOP2A—Retinoblastoma (RB) in Cancer—HMGB1—systemic lupus erythematosus	0.000409	0.00677	CbGpPWpGaD
Epirubicin—YWHAG—SIDS Susceptibility Pathways—IL1RN—systemic lupus erythematosus	0.000399	0.00659	CbGpPWpGaD
Epirubicin—YWHAG—FoxO family signaling—CDKN1B—systemic lupus erythematosus	0.000385	0.00636	CbGpPWpGaD
Epirubicin—PLA2G4A—PDGFR-beta signaling pathway—CSK—systemic lupus erythematosus	0.000372	0.00615	CbGpPWpGaD
Epirubicin—AURKA—Integrated Breast Cancer Pathway—JAK1—systemic lupus erythematosus	0.000369	0.00609	CbGpPWpGaD
Epirubicin—YWHAG—Apoptosis—HMGB1—systemic lupus erythematosus	0.000369	0.00609	CbGpPWpGaD
Epirubicin—PLA2G4A—Prostaglandin Synthesis and Regulation—PTGS2—systemic lupus erythematosus	0.000364	0.00602	CbGpPWpGaD
Epirubicin—AURKA—EGF/EGFR Signaling Pathway—JAK1—systemic lupus erythematosus	0.000349	0.00576	CbGpPWpGaD
Epirubicin—PLA2G4A—PDGFR-beta signaling pathway—LYN—systemic lupus erythematosus	0.000338	0.00559	CbGpPWpGaD
Epirubicin—YWHAG—FoxO family signaling—EP300—systemic lupus erythematosus	0.000338	0.00558	CbGpPWpGaD
Epirubicin—ABCC1—S1P1 pathway—VEGFA—systemic lupus erythematosus	0.00033	0.00546	CbGpPWpGaD
Epirubicin—UGT2B7—Biological oxidations—NAT2—systemic lupus erythematosus	0.00033	0.00545	CbGpPWpGaD
Epirubicin—UGT2B7—Metapathway biotransformation—NAT2—systemic lupus erythematosus	0.000325	0.00538	CbGpPWpGaD
Epirubicin—PLA2G4A—PDGFR-beta signaling pathway—BLK—systemic lupus erythematosus	0.000324	0.00535	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling mediated by p38-alpha and p38-beta—PTGS2—systemic lupus erythematosus	0.000322	0.00532	CbGpPWpGaD
Epirubicin—YWHAG—Role of Calcineurin-dependent NFAT signaling in lymphocytes—EP300—systemic lupus erythematosus	0.000313	0.00517	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle, Mitotic—HIST2H2AC—systemic lupus erythematosus	0.000287	0.00474	CbGpPWpGaD
Epirubicin—YWHAG—SIDS Susceptibility Pathways—IL10—systemic lupus erythematosus	0.000285	0.00471	CbGpPWpGaD
Epirubicin—YWHAG—Apoptosis—FASLG—systemic lupus erythematosus	0.000267	0.00441	CbGpPWpGaD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—CLU—systemic lupus erythematosus	0.000265	0.00438	CbGpPWpGaD
Epirubicin—YWHAG—SIDS Susceptibility Pathways—NR3C1—systemic lupus erythematosus	0.000264	0.00436	CbGpPWpGaD
Epirubicin—YWHAG—Apoptosis—FAS—systemic lupus erythematosus	0.000257	0.00425	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle—HIST2H2AC—systemic lupus erythematosus	0.000257	0.00424	CbGpPWpGaD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—P2RY12—systemic lupus erythematosus	0.000256	0.00424	CbGpPWpGaD
Epirubicin—PLA2G4A—Arachidonic acid metabolism—PTGS2—systemic lupus erythematosus	0.000242	0.004	CbGpPWpGaD
Epirubicin—YWHAG—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—systemic lupus erythematosus	0.000241	0.00398	CbGpPWpGaD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—CSK—systemic lupus erythematosus	0.000236	0.0039	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—GADD45A—systemic lupus erythematosus	0.000233	0.00385	CbGpPWpGaD
Epirubicin—AURKA—G2/M Transition—EP300—systemic lupus erythematosus	0.000228	0.00378	CbGpPWpGaD
Epirubicin—YWHAG—Regulation of nuclear beta catenin signaling and target gene transcription—EP300—systemic lupus erythematosus	0.000228	0.00377	CbGpPWpGaD
Epirubicin—AURKA—Mitotic G2-G2/M phases—EP300—systemic lupus erythematosus	0.000225	0.00372	CbGpPWpGaD
Epirubicin—AURKA—EGF/EGFR Signaling Pathway—NOS3—systemic lupus erythematosus	0.000225	0.00372	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—JUNB—systemic lupus erythematosus	0.00022	0.00363	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle, Mitotic—HIST2H2AC—systemic lupus erythematosus	0.000218	0.00359	CbGpPWpGaD
Epirubicin—TOP2A—Circadian rythm related genes—ADIPOQ—systemic lupus erythematosus	0.000216	0.00357	CbGpPWpGaD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—LYN—systemic lupus erythematosus	0.000214	0.00354	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—CDKN1B—systemic lupus erythematosus	0.000214	0.00354	CbGpPWpGaD
Epirubicin—PLA2G4A—AGE/RAGE pathway—NOS3—systemic lupus erythematosus	0.000212	0.0035	CbGpPWpGaD
Epirubicin—UGT2B7—NRF2 pathway—RXRA—systemic lupus erythematosus	0.000211	0.00349	CbGpPWpGaD
Epirubicin—ABCC1—Transmembrane transport of small molecules—SLC15A4—systemic lupus erythematosus	0.000208	0.00344	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	0.000206	0.0034	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—GADD45A—systemic lupus erythematosus	0.000202	0.00334	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—CDKN1A—systemic lupus erythematosus	0.000197	0.00326	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—HIST2H2AC—systemic lupus erythematosus	0.000194	0.00321	CbGpPWpGaD
Epirubicin—ABCC1—Arachidonic acid metabolism—PTGS2—systemic lupus erythematosus	0.000193	0.0032	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—RXRA—systemic lupus erythematosus	0.000193	0.00318	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—JUNB—systemic lupus erythematosus	0.00019	0.00315	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—EP300—systemic lupus erythematosus	0.000188	0.00311	CbGpPWpGaD
Epirubicin—PLA2G4A—Platelet homeostasis—NOS3—systemic lupus erythematosus	0.000185	0.00307	CbGpPWpGaD
Epirubicin—UGT2B7—Biological oxidations—RXRA—systemic lupus erythematosus	0.000185	0.00306	CbGpPWpGaD
Epirubicin—AURKA—Integrated Breast Cancer Pathway—EP300—systemic lupus erythematosus	0.000181	0.00299	CbGpPWpGaD
Epirubicin—YWHAG—Myometrial Relaxation and Contraction Pathways—NOS3—systemic lupus erythematosus	0.000177	0.00292	CbGpPWpGaD
Epirubicin—YWHAG—G2/M Transition—EP300—systemic lupus erythematosus	0.000173	0.00286	CbGpPWpGaD
Epirubicin—AURKA—Integrated Breast Cancer Pathway—VEGFA—systemic lupus erythematosus	0.000172	0.00284	CbGpPWpGaD
Epirubicin—YWHAG—Mitotic G2-G2/M phases—EP300—systemic lupus erythematosus	0.000171	0.00282	CbGpPWpGaD
Epirubicin—PLA2G4A—AGE/RAGE pathway—MMP9—systemic lupus erythematosus	0.00017	0.00281	CbGpPWpGaD
Epirubicin—TOP2A—Retinoblastoma (RB) in Cancer—CDKN1B—systemic lupus erythematosus	0.00017	0.00281	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—RXRA—systemic lupus erythematosus	0.000167	0.00276	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—NAT2—systemic lupus erythematosus	0.000164	0.0027	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—TGFB1—systemic lupus erythematosus	0.000163	0.0027	CbGpPWpGaD
Epirubicin—PLA2G4A—Dexamethasone—Hydrocortisone—systemic lupus erythematosus	0.000161	0.0211	CbGdCrCtD
Epirubicin—PLA2G4A—Betamethasone—Hydrocortisone—systemic lupus erythematosus	0.000161	0.0211	CbGdCrCtD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—RASGRP1—systemic lupus erythematosus	0.000161	0.00266	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—FASLG—systemic lupus erythematosus	0.000158	0.00261	CbGpPWpGaD
Epirubicin—TOP2A—Retinoblastoma (RB) in Cancer—CDKN1A—systemic lupus erythematosus	0.000157	0.00259	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—ITGAX—systemic lupus erythematosus	0.000153	0.00253	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle, Mitotic—HIST2H2AC—systemic lupus erythematosus	0.000152	0.00251	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—FAS—systemic lupus erythematosus	0.000152	0.00251	CbGpPWpGaD
Epirubicin—PLA2G4A—Betamethasone—Methylprednisolone—systemic lupus erythematosus	0.000152	0.0199	CbGdCrCtD
Epirubicin—PLA2G4A—Dexamethasone—Methylprednisolone—systemic lupus erythematosus	0.000152	0.0199	CbGdCrCtD
Epirubicin—PLA2G4A—Hemostasis—F3—systemic lupus erythematosus	0.000151	0.00249	CbGpPWpGaD
Epirubicin—PLA2G4A—Betamethasone—Dexamethasone—systemic lupus erythematosus	0.00015	0.0196	CbGdCrCtD
Epirubicin—PLA2G4A—Dexamethasone—Betamethasone—systemic lupus erythematosus	0.00015	0.0196	CbGdCrCtD
Epirubicin—PLA2G4A—Betamethasone—Triamcinolone—systemic lupus erythematosus	0.000146	0.0191	CbGdCrCtD
Epirubicin—PLA2G4A—Dexamethasone—Triamcinolone—systemic lupus erythematosus	0.000146	0.0191	CbGdCrCtD
Epirubicin—TOP2A—Circadian rythm related genes—FAS—systemic lupus erythematosus	0.000146	0.00241	CbGpPWpGaD
Epirubicin—PLA2G4A—Betamethasone—Prednisone—systemic lupus erythematosus	0.000139	0.0182	CbGdCrCtD
Epirubicin—PLA2G4A—Dexamethasone—Prednisone—systemic lupus erythematosus	0.000139	0.0182	CbGdCrCtD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—FASLG—systemic lupus erythematosus	0.000137	0.00226	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—CLU—systemic lupus erythematosus	0.000137	0.00226	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—HIST2H2AC—systemic lupus erythematosus	0.000136	0.00225	CbGpPWpGaD
Epirubicin—PLA2G4A—Betamethasone—Prednisolone—systemic lupus erythematosus	0.000135	0.0177	CbGdCrCtD
Epirubicin—PLA2G4A—Dexamethasone—Prednisolone—systemic lupus erythematosus	0.000135	0.0177	CbGdCrCtD
Epirubicin—YWHAG—SIDS Susceptibility Pathways—EP300—systemic lupus erythematosus	0.000134	0.00221	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—P2RY12—systemic lupus erythematosus	0.000132	0.00219	CbGpPWpGaD
Epirubicin—TOP2A—Methyltestosterone—Hydrocortisone—systemic lupus erythematosus	0.000132	0.0173	CbGdCrCtD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—FAS—systemic lupus erythematosus	0.000132	0.00218	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	0.00013	0.00215	CbGpPWpGaD
Epirubicin—YWHAG—SIDS Susceptibility Pathways—VEGFA—systemic lupus erythematosus	0.000127	0.00209	CbGpPWpGaD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—JAK1—systemic lupus erythematosus	0.000125	0.00206	CbGpPWpGaD
Epirubicin—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—systemic lupus erythematosus	0.000124	0.00205	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—CSK—systemic lupus erythematosus	0.000122	0.00201	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—SELE—systemic lupus erythematosus	0.000122	0.00201	CbGpPWpGaD
Epirubicin—TOP2A—Mitotic G1-G1/S phases—CDKN1B—systemic lupus erythematosus	0.00012	0.00198	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	0.000117	0.00193	CbGpPWpGaD
Epirubicin—TOP2A—Circadian rythm related genes—PPARG—systemic lupus erythematosus	0.000117	0.00193	CbGpPWpGaD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—IL2RA—systemic lupus erythematosus	0.000117	0.00193	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—ITGAM—systemic lupus erythematosus	0.000114	0.00189	CbGpPWpGaD
Epirubicin—TOP2A—Methyltestosterone—Prednisone—systemic lupus erythematosus	0.000114	0.0149	CbGdCrCtD
Epirubicin—TOP2A—Methyltestosterone—Prednisolone—systemic lupus erythematosus	0.000111	0.0145	CbGdCrCtD
Epirubicin—PLA2G4A—Hemostasis—LYN—systemic lupus erythematosus	0.000111	0.00183	CbGpPWpGaD
Epirubicin—TOP2A—Mitotic G1-G1/S phases—CDKN1A—systemic lupus erythematosus	0.00011	0.00182	CbGpPWpGaD
Epirubicin—YWHAG—Apoptosis—TNF—systemic lupus erythematosus	0.000109	0.0018	CbGpPWpGaD
Epirubicin—YWHAG—SIDS Susceptibility Pathways—TNF—systemic lupus erythematosus	0.000109	0.00179	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—SH2B3—systemic lupus erythematosus	0.000108	0.00179	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	0.000102	0.00169	CbGpPWpGaD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—F2—systemic lupus erythematosus	0.000101	0.00168	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—systemic lupus erythematosus	9.57e-05	0.00158	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—RXRA—systemic lupus erythematosus	9.17e-05	0.00151	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1B—systemic lupus erythematosus	9.06e-05	0.0015	CbGpPWpGaD
Epirubicin—YWHAG—Myometrial Relaxation and Contraction Pathways—IL6—systemic lupus erythematosus	8.81e-05	0.00146	CbGpPWpGaD
Epirubicin—YWHAG—SIDS Susceptibility Pathways—IL6—systemic lupus erythematosus	8.76e-05	0.00145	CbGpPWpGaD
Epirubicin—TOP2A—Norethindrone—Hydrocortisone—systemic lupus erythematosus	8.61e-05	0.0113	CbGdCrCtD
Epirubicin—PLA2G4A—Hemostasis—IFNA1—systemic lupus erythematosus	8.52e-05	0.00141	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	8.5e-05	0.00141	CbGpPWpGaD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—ALB—systemic lupus erythematosus	8.43e-05	0.00139	CbGpPWpGaD
Epirubicin—Oedema—Dexamethasone—systemic lupus erythematosus	8.36e-05	0.000199	CcSEcCtD
Epirubicin—Anaphylactic shock—Dexamethasone—systemic lupus erythematosus	8.36e-05	0.000199	CcSEcCtD
Epirubicin—Oedema—Betamethasone—systemic lupus erythematosus	8.36e-05	0.000199	CcSEcCtD
Epirubicin—Anaphylactic shock—Betamethasone—systemic lupus erythematosus	8.36e-05	0.000199	CcSEcCtD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1A—systemic lupus erythematosus	8.36e-05	0.00138	CbGpPWpGaD
Epirubicin—Insomnia—Triamcinolone—systemic lupus erythematosus	8.34e-05	0.000198	CcSEcCtD
Epirubicin—Insomnia—Methylprednisolone—systemic lupus erythematosus	8.32e-05	0.000198	CcSEcCtD
Epirubicin—Infection—Dexamethasone—systemic lupus erythematosus	8.31e-05	0.000198	CcSEcCtD
Epirubicin—Infection—Betamethasone—systemic lupus erythematosus	8.31e-05	0.000198	CcSEcCtD
Epirubicin—PLA2G4A—Hemostasis—RASGRP1—systemic lupus erythematosus	8.3e-05	0.00137	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—PTGS2—systemic lupus erythematosus	8.29e-05	0.00137	CbGpPWpGaD
Epirubicin—Ill-defined disorder—Prednisone—systemic lupus erythematosus	8.28e-05	0.000197	CcSEcCtD
Epirubicin—Paraesthesia—Triamcinolone—systemic lupus erythematosus	8.28e-05	0.000197	CcSEcCtD
Epirubicin—AURKA—Cell Cycle, Mitotic—CDKN1B—systemic lupus erythematosus	8.28e-05	0.00137	CbGpPWpGaD
Epirubicin—Feeling abnormal—Prednisolone—systemic lupus erythematosus	8.26e-05	0.000196	CcSEcCtD
Epirubicin—Paraesthesia—Methylprednisolone—systemic lupus erythematosus	8.26e-05	0.000196	CcSEcCtD
Epirubicin—Visual impairment—Methotrexate—systemic lupus erythematosus	8.26e-05	0.000196	CcSEcCtD
Epirubicin—Anaemia—Prednisone—systemic lupus erythematosus	8.25e-05	0.000196	CcSEcCtD
Epirubicin—Shock—Dexamethasone—systemic lupus erythematosus	8.23e-05	0.000196	CcSEcCtD
Epirubicin—Shock—Betamethasone—systemic lupus erythematosus	8.23e-05	0.000196	CcSEcCtD
Epirubicin—Dyspnoea—Triamcinolone—systemic lupus erythematosus	8.22e-05	0.000195	CcSEcCtD
Epirubicin—Nervous system disorder—Betamethasone—systemic lupus erythematosus	8.2e-05	0.000195	CcSEcCtD
Epirubicin—Nervous system disorder—Dexamethasone—systemic lupus erythematosus	8.2e-05	0.000195	CcSEcCtD
Epirubicin—Agitation—Prednisone—systemic lupus erythematosus	8.2e-05	0.000195	CcSEcCtD
Epirubicin—Thrombocytopenia—Betamethasone—systemic lupus erythematosus	8.19e-05	0.000195	CcSEcCtD
Epirubicin—Thrombocytopenia—Dexamethasone—systemic lupus erythematosus	8.19e-05	0.000195	CcSEcCtD
Epirubicin—Tachycardia—Dexamethasone—systemic lupus erythematosus	8.16e-05	0.000194	CcSEcCtD
Epirubicin—Tachycardia—Betamethasone—systemic lupus erythematosus	8.16e-05	0.000194	CcSEcCtD
Epirubicin—Hypersensitivity—Cyclosporine—systemic lupus erythematosus	8.12e-05	0.000193	CcSEcCtD
Epirubicin—Dyspepsia—Triamcinolone—systemic lupus erythematosus	8.11e-05	0.000193	CcSEcCtD
Epirubicin—Erythema multiforme—Methotrexate—systemic lupus erythematosus	8.1e-05	0.000193	CcSEcCtD
Epirubicin—Dyspepsia—Methylprednisolone—systemic lupus erythematosus	8.1e-05	0.000193	CcSEcCtD
Epirubicin—Hyperhidrosis—Dexamethasone—systemic lupus erythematosus	8.09e-05	0.000192	CcSEcCtD
Epirubicin—Hyperhidrosis—Betamethasone—systemic lupus erythematosus	8.09e-05	0.000192	CcSEcCtD
Epirubicin—Feeling abnormal—Hydrocortisone—systemic lupus erythematosus	8.07e-05	0.000192	CcSEcCtD
Epirubicin—Malaise—Prednisone—systemic lupus erythematosus	8.05e-05	0.000191	CcSEcCtD
Epirubicin—Vertigo—Prednisone—systemic lupus erythematosus	8.02e-05	0.000191	CcSEcCtD
Epirubicin—Eye disorder—Methotrexate—systemic lupus erythematosus	8.01e-05	0.00019	CcSEcCtD
Epirubicin—Gastrointestinal pain—Hydrocortisone—systemic lupus erythematosus	8e-05	0.00019	CcSEcCtD
Epirubicin—Syncope—Prednisone—systemic lupus erythematosus	8e-05	0.00019	CcSEcCtD
Epirubicin—Tinnitus—Methotrexate—systemic lupus erythematosus	7.99e-05	0.00019	CcSEcCtD
Epirubicin—Anorexia—Betamethasone—systemic lupus erythematosus	7.97e-05	0.00019	CcSEcCtD
Epirubicin—Anorexia—Dexamethasone—systemic lupus erythematosus	7.97e-05	0.00019	CcSEcCtD
Epirubicin—Urticaria—Prednisolone—systemic lupus erythematosus	7.96e-05	0.000189	CcSEcCtD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—EP300—systemic lupus erythematosus	7.96e-05	0.00132	CbGpPWpGaD
Epirubicin—Cardiac disorder—Methotrexate—systemic lupus erythematosus	7.95e-05	0.000189	CcSEcCtD
Epirubicin—Fatigue—Triamcinolone—systemic lupus erythematosus	7.95e-05	0.000189	CcSEcCtD
Epirubicin—Fatigue—Methylprednisolone—systemic lupus erythematosus	7.93e-05	0.000189	CcSEcCtD
Epirubicin—Hypersensitivity—Mycophenolate mofetil—systemic lupus erythematosus	7.92e-05	0.000188	CcSEcCtD
Epirubicin—Asthenia—Cyclosporine—systemic lupus erythematosus	7.9e-05	0.000188	CcSEcCtD
Epirubicin—Pain—Triamcinolone—systemic lupus erythematosus	7.88e-05	0.000187	CcSEcCtD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—CDKN1B—systemic lupus erythematosus	7.85e-05	0.0013	CbGpPWpGaD
Epirubicin—Loss of consciousness—Prednisone—systemic lupus erythematosus	7.84e-05	0.000187	CcSEcCtD
Epirubicin—Hypotension—Betamethasone—systemic lupus erythematosus	7.82e-05	0.000186	CcSEcCtD
Epirubicin—Hypotension—Dexamethasone—systemic lupus erythematosus	7.82e-05	0.000186	CcSEcCtD
Epirubicin—Pruritus—Cyclosporine—systemic lupus erythematosus	7.79e-05	0.000185	CcSEcCtD
Epirubicin—Urticaria—Hydrocortisone—systemic lupus erythematosus	7.78e-05	0.000185	CcSEcCtD
Epirubicin—Angiopathy—Methotrexate—systemic lupus erythematosus	7.77e-05	0.000185	CcSEcCtD
Epirubicin—Immune system disorder—Methotrexate—systemic lupus erythematosus	7.74e-05	0.000184	CcSEcCtD
Epirubicin—Abdominal pain—Hydrocortisone—systemic lupus erythematosus	7.74e-05	0.000184	CcSEcCtD
Epirubicin—Body temperature increased—Hydrocortisone—systemic lupus erythematosus	7.74e-05	0.000184	CcSEcCtD
Epirubicin—Convulsion—Prednisone—systemic lupus erythematosus	7.73e-05	0.000184	CcSEcCtD
Epirubicin—Mediastinal disorder—Methotrexate—systemic lupus erythematosus	7.72e-05	0.000184	CcSEcCtD
Epirubicin—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	7.71e-05	0.000183	CcSEcCtD
Epirubicin—Hypertension—Prednisone—systemic lupus erythematosus	7.71e-05	0.000183	CcSEcCtD
Epirubicin—Chills—Methotrexate—systemic lupus erythematosus	7.69e-05	0.000183	CcSEcCtD
Epirubicin—TOP2A—Circadian rythm related genes—EP300—systemic lupus erythematosus	7.64e-05	0.00126	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle, Mitotic—CDKN1A—systemic lupus erythematosus	7.64e-05	0.00126	CbGpPWpGaD
Epirubicin—Musculoskeletal discomfort—Betamethasone—systemic lupus erythematosus	7.62e-05	0.000181	CcSEcCtD
Epirubicin—Musculoskeletal discomfort—Dexamethasone—systemic lupus erythematosus	7.62e-05	0.000181	CcSEcCtD
Epirubicin—Pruritus—Mycophenolate mofetil—systemic lupus erythematosus	7.6e-05	0.000181	CcSEcCtD
Epirubicin—Arthralgia—Prednisone—systemic lupus erythematosus	7.6e-05	0.000181	CcSEcCtD
Epirubicin—Myalgia—Prednisone—systemic lupus erythematosus	7.6e-05	0.000181	CcSEcCtD
Epirubicin—Feeling abnormal—Triamcinolone—systemic lupus erythematosus	7.6e-05	0.000181	CcSEcCtD
Epirubicin—PLA2G4A—Signaling by GPCR—P2RY12—systemic lupus erythematosus	7.59e-05	0.00125	CbGpPWpGaD
Epirubicin—Feeling abnormal—Methylprednisolone—systemic lupus erythematosus	7.58e-05	0.00018	CcSEcCtD
Epirubicin—UGT2B7—NRF2 pathway—TGFB1—systemic lupus erythematosus	7.57e-05	0.00125	CbGpPWpGaD
Epirubicin—Anxiety—Prednisone—systemic lupus erythematosus	7.57e-05	0.00018	CcSEcCtD
Epirubicin—Alopecia—Methotrexate—systemic lupus erythematosus	7.57e-05	0.00018	CcSEcCtD
Epirubicin—Insomnia—Dexamethasone—systemic lupus erythematosus	7.56e-05	0.00018	CcSEcCtD
Epirubicin—Insomnia—Betamethasone—systemic lupus erythematosus	7.56e-05	0.00018	CcSEcCtD
Epirubicin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic lupus erythematosus	7.55e-05	0.000179	CcSEcCtD
Epirubicin—Diarrhoea—Cyclosporine—systemic lupus erythematosus	7.54e-05	0.000179	CcSEcCtD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—systemic lupus erythematosus	7.54e-05	0.00125	CbGpPWpGaD
Epirubicin—Gastrointestinal pain—Methylprednisolone—systemic lupus erythematosus	7.52e-05	0.000179	CcSEcCtD
Epirubicin—Paraesthesia—Dexamethasone—systemic lupus erythematosus	7.51e-05	0.000179	CcSEcCtD
Epirubicin—Paraesthesia—Betamethasone—systemic lupus erythematosus	7.51e-05	0.000179	CcSEcCtD
Epirubicin—Discomfort—Prednisone—systemic lupus erythematosus	7.51e-05	0.000179	CcSEcCtD
Epirubicin—Mental disorder—Methotrexate—systemic lupus erythematosus	7.51e-05	0.000179	CcSEcCtD
Epirubicin—Erythema—Methotrexate—systemic lupus erythematosus	7.46e-05	0.000177	CcSEcCtD
Epirubicin—Malnutrition—Methotrexate—systemic lupus erythematosus	7.46e-05	0.000177	CcSEcCtD
Epirubicin—AURKA—Cell Cycle—CDKN1B—systemic lupus erythematosus	7.4e-05	0.00122	CbGpPWpGaD
Epirubicin—Hypersensitivity—Prednisolone—systemic lupus erythematosus	7.38e-05	0.000176	CcSEcCtD
Epirubicin—Dyspepsia—Dexamethasone—systemic lupus erythematosus	7.36e-05	0.000175	CcSEcCtD
Epirubicin—Dyspepsia—Betamethasone—systemic lupus erythematosus	7.36e-05	0.000175	CcSEcCtD
Epirubicin—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	7.35e-05	0.000175	CcSEcCtD
Epirubicin—Urticaria—Triamcinolone—systemic lupus erythematosus	7.32e-05	0.000174	CcSEcCtD
Epirubicin—Urticaria—Methylprednisolone—systemic lupus erythematosus	7.31e-05	0.000174	CcSEcCtD
Epirubicin—Dysgeusia—Methotrexate—systemic lupus erythematosus	7.3e-05	0.000174	CcSEcCtD
Epirubicin—Body temperature increased—Triamcinolone—systemic lupus erythematosus	7.29e-05	0.000173	CcSEcCtD
Epirubicin—Dizziness—Cyclosporine—systemic lupus erythematosus	7.28e-05	0.000173	CcSEcCtD
Epirubicin—Anaphylactic shock—Prednisone—systemic lupus erythematosus	7.28e-05	0.000173	CcSEcCtD
Epirubicin—Oedema—Prednisone—systemic lupus erythematosus	7.28e-05	0.000173	CcSEcCtD
Epirubicin—Abdominal pain—Methylprednisolone—systemic lupus erythematosus	7.27e-05	0.000173	CcSEcCtD
Epirubicin—Decreased appetite—Dexamethasone—systemic lupus erythematosus	7.27e-05	0.000173	CcSEcCtD
Epirubicin—Decreased appetite—Betamethasone—systemic lupus erythematosus	7.27e-05	0.000173	CcSEcCtD
Epirubicin—AURKA—Cell Cycle, Mitotic—EP300—systemic lupus erythematosus	7.27e-05	0.0012	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—CDKN1A—systemic lupus erythematosus	7.24e-05	0.0012	CbGpPWpGaD
Epirubicin—Infection—Prednisone—systemic lupus erythematosus	7.24e-05	0.000172	CcSEcCtD
Epirubicin—Gastrointestinal disorder—Betamethasone—systemic lupus erythematosus	7.22e-05	0.000172	CcSEcCtD
Epirubicin—Gastrointestinal disorder—Dexamethasone—systemic lupus erythematosus	7.22e-05	0.000172	CcSEcCtD
Epirubicin—Back pain—Methotrexate—systemic lupus erythematosus	7.21e-05	0.000172	CcSEcCtD
Epirubicin—Hypersensitivity—Hydrocortisone—systemic lupus erythematosus	7.21e-05	0.000172	CcSEcCtD
Epirubicin—Fatigue—Dexamethasone—systemic lupus erythematosus	7.21e-05	0.000172	CcSEcCtD
Epirubicin—Fatigue—Betamethasone—systemic lupus erythematosus	7.21e-05	0.000172	CcSEcCtD
Epirubicin—Shock—Prednisone—systemic lupus erythematosus	7.17e-05	0.00017	CcSEcCtD
Epirubicin—Pain—Betamethasone—systemic lupus erythematosus	7.15e-05	0.00017	CcSEcCtD
Epirubicin—Pain—Dexamethasone—systemic lupus erythematosus	7.15e-05	0.00017	CcSEcCtD
Epirubicin—Nervous system disorder—Prednisone—systemic lupus erythematosus	7.14e-05	0.00017	CcSEcCtD
Epirubicin—Tachycardia—Prednisone—systemic lupus erythematosus	7.11e-05	0.000169	CcSEcCtD
Epirubicin—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	7.11e-05	0.000169	CcSEcCtD
Epirubicin—Skin disorder—Prednisone—systemic lupus erythematosus	7.07e-05	0.000168	CcSEcCtD
Epirubicin—Hyperhidrosis—Prednisone—systemic lupus erythematosus	7.04e-05	0.000167	CcSEcCtD
Epirubicin—Vision blurred—Methotrexate—systemic lupus erythematosus	7.03e-05	0.000167	CcSEcCtD
Epirubicin—Asthenia—Hydrocortisone—systemic lupus erythematosus	7.02e-05	0.000167	CcSEcCtD
Epirubicin—Vomiting—Cyclosporine—systemic lupus erythematosus	7e-05	0.000167	CcSEcCtD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	6.97e-05	0.00115	CbGpPWpGaD
Epirubicin—Rash—Cyclosporine—systemic lupus erythematosus	6.95e-05	0.000165	CcSEcCtD
Epirubicin—Anorexia—Prednisone—systemic lupus erythematosus	6.94e-05	0.000165	CcSEcCtD
Epirubicin—Dermatitis—Cyclosporine—systemic lupus erythematosus	6.94e-05	0.000165	CcSEcCtD
Epirubicin—Pruritus—Hydrocortisone—systemic lupus erythematosus	6.93e-05	0.000165	CcSEcCtD
Epirubicin—Ill-defined disorder—Methotrexate—systemic lupus erythematosus	6.92e-05	0.000165	CcSEcCtD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TGFB1—systemic lupus erythematosus	6.92e-05	0.00114	CbGpPWpGaD
Epirubicin—Headache—Cyclosporine—systemic lupus erythematosus	6.9e-05	0.000164	CcSEcCtD
Epirubicin—Anaemia—Methotrexate—systemic lupus erythematosus	6.89e-05	0.000164	CcSEcCtD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—EP300—systemic lupus erythematosus	6.89e-05	0.00114	CbGpPWpGaD
Epirubicin—Feeling abnormal—Dexamethasone—systemic lupus erythematosus	6.89e-05	0.000164	CcSEcCtD
Epirubicin—Feeling abnormal—Betamethasone—systemic lupus erythematosus	6.89e-05	0.000164	CcSEcCtD
Epirubicin—TOP2A—Levonorgestrel—Hydrocortisone—systemic lupus erythematosus	6.85e-05	0.00897	CbGdCrCtD
Epirubicin—Gastrointestinal pain—Dexamethasone—systemic lupus erythematosus	6.84e-05	0.000163	CcSEcCtD
Epirubicin—Gastrointestinal pain—Betamethasone—systemic lupus erythematosus	6.84e-05	0.000163	CcSEcCtD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—IL2—systemic lupus erythematosus	6.83e-05	0.00113	CbGpPWpGaD
Epirubicin—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	6.83e-05	0.000163	CcSEcCtD
Epirubicin—AURKA—Cell Cycle—CDKN1A—systemic lupus erythematosus	6.83e-05	0.00113	CbGpPWpGaD
Epirubicin—Hypersensitivity—Triamcinolone—systemic lupus erythematosus	6.79e-05	0.000162	CcSEcCtD
Epirubicin—Hypersensitivity—Methylprednisolone—systemic lupus erythematosus	6.78e-05	0.000161	CcSEcCtD
Epirubicin—Rash—Mycophenolate mofetil—systemic lupus erythematosus	6.78e-05	0.000161	CcSEcCtD
Epirubicin—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	6.77e-05	0.000161	CcSEcCtD
Epirubicin—Headache—Mycophenolate mofetil—systemic lupus erythematosus	6.73e-05	0.00016	CcSEcCtD
Epirubicin—Malaise—Methotrexate—systemic lupus erythematosus	6.73e-05	0.00016	CcSEcCtD
Epirubicin—Vertigo—Methotrexate—systemic lupus erythematosus	6.7e-05	0.000159	CcSEcCtD
Epirubicin—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	6.7e-05	0.000159	CcSEcCtD
Epirubicin—Leukopenia—Methotrexate—systemic lupus erythematosus	6.68e-05	0.000159	CcSEcCtD
Epirubicin—Urticaria—Dexamethasone—systemic lupus erythematosus	6.64e-05	0.000158	CcSEcCtD
Epirubicin—Urticaria—Betamethasone—systemic lupus erythematosus	6.64e-05	0.000158	CcSEcCtD
Epirubicin—Musculoskeletal discomfort—Prednisone—systemic lupus erythematosus	6.64e-05	0.000158	CcSEcCtD
Epirubicin—Dizziness—Prednisolone—systemic lupus erythematosus	6.63e-05	0.000158	CcSEcCtD
Epirubicin—Asthenia—Triamcinolone—systemic lupus erythematosus	6.61e-05	0.000157	CcSEcCtD
Epirubicin—Body temperature increased—Dexamethasone—systemic lupus erythematosus	6.61e-05	0.000157	CcSEcCtD
Epirubicin—Abdominal pain—Betamethasone—systemic lupus erythematosus	6.61e-05	0.000157	CcSEcCtD
Epirubicin—Body temperature increased—Betamethasone—systemic lupus erythematosus	6.61e-05	0.000157	CcSEcCtD
Epirubicin—Abdominal pain—Dexamethasone—systemic lupus erythematosus	6.61e-05	0.000157	CcSEcCtD
Epirubicin—Asthenia—Methylprednisolone—systemic lupus erythematosus	6.6e-05	0.000157	CcSEcCtD
Epirubicin—Insomnia—Prednisone—systemic lupus erythematosus	6.59e-05	0.000157	CcSEcCtD
Epirubicin—ABCC1—Disease—XRCC6—systemic lupus erythematosus	6.55e-05	0.00108	CbGpPWpGaD
Epirubicin—Nausea—Cyclosporine—systemic lupus erythematosus	6.54e-05	0.000156	CcSEcCtD
Epirubicin—Paraesthesia—Prednisone—systemic lupus erythematosus	6.54e-05	0.000156	CcSEcCtD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—VEGFA—systemic lupus erythematosus	6.53e-05	0.00108	CbGpPWpGaD
Epirubicin—Pruritus—Triamcinolone—systemic lupus erythematosus	6.52e-05	0.000155	CcSEcCtD
Epirubicin—Cough—Methotrexate—systemic lupus erythematosus	6.51e-05	0.000155	CcSEcCtD
Epirubicin—Pruritus—Methylprednisolone—systemic lupus erythematosus	6.51e-05	0.000155	CcSEcCtD
Epirubicin—AURKA—Cell Cycle—EP300—systemic lupus erythematosus	6.5e-05	0.00107	CbGpPWpGaD
Epirubicin—Dizziness—Hydrocortisone—systemic lupus erythematosus	6.47e-05	0.000154	CcSEcCtD
Epirubicin—Convulsion—Methotrexate—systemic lupus erythematosus	6.46e-05	0.000154	CcSEcCtD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—systemic lupus erythematosus	6.46e-05	0.00107	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—JAK1—systemic lupus erythematosus	6.43e-05	0.00106	CbGpPWpGaD
Epirubicin—Dyspepsia—Prednisone—systemic lupus erythematosus	6.41e-05	0.000153	CcSEcCtD
Epirubicin—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	6.38e-05	0.000152	CcSEcCtD
Epirubicin—Arthralgia—Methotrexate—systemic lupus erythematosus	6.35e-05	0.000151	CcSEcCtD
Epirubicin—Chest pain—Methotrexate—systemic lupus erythematosus	6.35e-05	0.000151	CcSEcCtD
Epirubicin—Myalgia—Methotrexate—systemic lupus erythematosus	6.35e-05	0.000151	CcSEcCtD
Epirubicin—Decreased appetite—Prednisone—systemic lupus erythematosus	6.33e-05	0.000151	CcSEcCtD
Epirubicin—Rash—Prednisolone—systemic lupus erythematosus	6.32e-05	0.00015	CcSEcCtD
Epirubicin—Dermatitis—Prednisolone—systemic lupus erythematosus	6.31e-05	0.00015	CcSEcCtD
Epirubicin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic lupus erythematosus	6.31e-05	0.00015	CcSEcCtD
Epirubicin—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	6.29e-05	0.00015	CcSEcCtD
Epirubicin—Fatigue—Prednisone—systemic lupus erythematosus	6.28e-05	0.000149	CcSEcCtD
Epirubicin—Headache—Prednisolone—systemic lupus erythematosus	6.28e-05	0.000149	CcSEcCtD
Epirubicin—Discomfort—Methotrexate—systemic lupus erythematosus	6.27e-05	0.000149	CcSEcCtD
Epirubicin—YWHAG—Cell Cycle, Mitotic—CDKN1B—systemic lupus erythematosus	6.27e-05	0.00104	CbGpPWpGaD
Epirubicin—Constipation—Prednisone—systemic lupus erythematosus	6.23e-05	0.000148	CcSEcCtD
Epirubicin—Vomiting—Hydrocortisone—systemic lupus erythematosus	6.22e-05	0.000148	CcSEcCtD
Epirubicin—Rash—Hydrocortisone—systemic lupus erythematosus	6.17e-05	0.000147	CcSEcCtD
Epirubicin—Dermatitis—Hydrocortisone—systemic lupus erythematosus	6.17e-05	0.000147	CcSEcCtD
Epirubicin—Confusional state—Methotrexate—systemic lupus erythematosus	6.14e-05	0.000146	CcSEcCtD
Epirubicin—Headache—Hydrocortisone—systemic lupus erythematosus	6.13e-05	0.000146	CcSEcCtD
Epirubicin—Dizziness—Triamcinolone—systemic lupus erythematosus	6.1e-05	0.000145	CcSEcCtD
Epirubicin—Anaphylactic shock—Methotrexate—systemic lupus erythematosus	6.09e-05	0.000145	CcSEcCtD
Epirubicin—Dizziness—Methylprednisolone—systemic lupus erythematosus	6.08e-05	0.000145	CcSEcCtD
Epirubicin—Infection—Methotrexate—systemic lupus erythematosus	6.05e-05	0.000144	CcSEcCtD
Epirubicin—PLA2G4A—Hemostasis—IL2RA—systemic lupus erythematosus	6.01e-05	0.000993	CbGpPWpGaD
Epirubicin—Feeling abnormal—Prednisone—systemic lupus erythematosus	6e-05	0.000143	CcSEcCtD
Epirubicin—Asthenia—Betamethasone—systemic lupus erythematosus	6e-05	0.000143	CcSEcCtD
Epirubicin—Asthenia—Dexamethasone—systemic lupus erythematosus	6e-05	0.000143	CcSEcCtD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—TGFB1—systemic lupus erythematosus	5.99e-05	0.00099	CbGpPWpGaD
Epirubicin—Nervous system disorder—Methotrexate—systemic lupus erythematosus	5.97e-05	0.000142	CcSEcCtD
Epirubicin—Thrombocytopenia—Methotrexate—systemic lupus erythematosus	5.96e-05	0.000142	CcSEcCtD
Epirubicin—Gastrointestinal pain—Prednisone—systemic lupus erythematosus	5.96e-05	0.000142	CcSEcCtD
Epirubicin—Nausea—Prednisolone—systemic lupus erythematosus	5.95e-05	0.000142	CcSEcCtD
Epirubicin—Pruritus—Dexamethasone—systemic lupus erythematosus	5.92e-05	0.000141	CcSEcCtD
Epirubicin—Pruritus—Betamethasone—systemic lupus erythematosus	5.92e-05	0.000141	CcSEcCtD
Epirubicin—Skin disorder—Methotrexate—systemic lupus erythematosus	5.91e-05	0.000141	CcSEcCtD
Epirubicin—Hyperhidrosis—Methotrexate—systemic lupus erythematosus	5.88e-05	0.00014	CcSEcCtD
Epirubicin—Vomiting—Triamcinolone—systemic lupus erythematosus	5.86e-05	0.000139	CcSEcCtD
Epirubicin—Vomiting—Methylprednisolone—systemic lupus erythematosus	5.85e-05	0.000139	CcSEcCtD
Epirubicin—Nausea—Hydrocortisone—systemic lupus erythematosus	5.81e-05	0.000138	CcSEcCtD
Epirubicin—Rash—Triamcinolone—systemic lupus erythematosus	5.81e-05	0.000138	CcSEcCtD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—VEGFA—systemic lupus erythematosus	5.81e-05	0.00096	CbGpPWpGaD
Epirubicin—Dermatitis—Triamcinolone—systemic lupus erythematosus	5.81e-05	0.000138	CcSEcCtD
Epirubicin—Anorexia—Methotrexate—systemic lupus erythematosus	5.8e-05	0.000138	CcSEcCtD
Epirubicin—Rash—Methylprednisolone—systemic lupus erythematosus	5.8e-05	0.000138	CcSEcCtD
Epirubicin—Dermatitis—Methylprednisolone—systemic lupus erythematosus	5.79e-05	0.000138	CcSEcCtD
Epirubicin—YWHAG—Cell Cycle, Mitotic—CDKN1A—systemic lupus erythematosus	5.79e-05	0.000957	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—PPARG—systemic lupus erythematosus	5.79e-05	0.000957	CbGpPWpGaD
Epirubicin—Urticaria—Prednisone—systemic lupus erythematosus	5.79e-05	0.000138	CcSEcCtD
Epirubicin—Headache—Triamcinolone—systemic lupus erythematosus	5.77e-05	0.000137	CcSEcCtD
Epirubicin—Headache—Methylprednisolone—systemic lupus erythematosus	5.76e-05	0.000137	CcSEcCtD
Epirubicin—Body temperature increased—Prednisone—systemic lupus erythematosus	5.76e-05	0.000137	CcSEcCtD
Epirubicin—Abdominal pain—Prednisone—systemic lupus erythematosus	5.76e-05	0.000137	CcSEcCtD
Epirubicin—Diarrhoea—Dexamethasone—systemic lupus erythematosus	5.72e-05	0.000136	CcSEcCtD
Epirubicin—Diarrhoea—Betamethasone—systemic lupus erythematosus	5.72e-05	0.000136	CcSEcCtD
Epirubicin—Hypotension—Methotrexate—systemic lupus erythematosus	5.69e-05	0.000135	CcSEcCtD
Epirubicin—UGT2B7—Metabolism—NAT2—systemic lupus erythematosus	5.64e-05	0.000933	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—CDKN1B—systemic lupus erythematosus	5.61e-05	0.000927	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—TNF—systemic lupus erythematosus	5.59e-05	0.000925	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	5.57e-05	0.00092	CbGpPWpGaD
Epirubicin—Musculoskeletal discomfort—Methotrexate—systemic lupus erythematosus	5.55e-05	0.000132	CcSEcCtD
Epirubicin—PLA2G4A—Metabolism—NAT2—systemic lupus erythematosus	5.53e-05	0.000915	CbGpPWpGaD
Epirubicin—Dizziness—Betamethasone—systemic lupus erythematosus	5.53e-05	0.000132	CcSEcCtD
Epirubicin—Dizziness—Dexamethasone—systemic lupus erythematosus	5.53e-05	0.000132	CcSEcCtD
Epirubicin—YWHAG—Cell Cycle, Mitotic—EP300—systemic lupus erythematosus	5.51e-05	0.00091	CbGpPWpGaD
Epirubicin—Insomnia—Methotrexate—systemic lupus erythematosus	5.51e-05	0.000131	CcSEcCtD
Epirubicin—Nausea—Triamcinolone—systemic lupus erythematosus	5.48e-05	0.00013	CcSEcCtD
Epirubicin—Paraesthesia—Methotrexate—systemic lupus erythematosus	5.47e-05	0.00013	CcSEcCtD
Epirubicin—Nausea—Methylprednisolone—systemic lupus erythematosus	5.46e-05	0.00013	CcSEcCtD
Epirubicin—Dyspnoea—Methotrexate—systemic lupus erythematosus	5.43e-05	0.000129	CcSEcCtD
Epirubicin—Somnolence—Methotrexate—systemic lupus erythematosus	5.41e-05	0.000129	CcSEcCtD
Epirubicin—Hypersensitivity—Prednisone—systemic lupus erythematosus	5.37e-05	0.000128	CcSEcCtD
Epirubicin—Dyspepsia—Methotrexate—systemic lupus erythematosus	5.36e-05	0.000127	CcSEcCtD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—TGFB1—systemic lupus erythematosus	5.33e-05	0.000881	CbGpPWpGaD
Epirubicin—Vomiting—Dexamethasone—systemic lupus erythematosus	5.32e-05	0.000126	CcSEcCtD
Epirubicin—Vomiting—Betamethasone—systemic lupus erythematosus	5.32e-05	0.000126	CcSEcCtD
Epirubicin—ABCC1—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	5.29e-05	0.000875	CbGpPWpGaD
Epirubicin—Decreased appetite—Methotrexate—systemic lupus erythematosus	5.29e-05	0.000126	CcSEcCtD
Epirubicin—Rash—Dexamethasone—systemic lupus erythematosus	5.27e-05	0.000125	CcSEcCtD
Epirubicin—Rash—Betamethasone—systemic lupus erythematosus	5.27e-05	0.000125	CcSEcCtD
Epirubicin—Dermatitis—Betamethasone—systemic lupus erythematosus	5.27e-05	0.000125	CcSEcCtD
Epirubicin—Dermatitis—Dexamethasone—systemic lupus erythematosus	5.27e-05	0.000125	CcSEcCtD
Epirubicin—Gastrointestinal disorder—Methotrexate—systemic lupus erythematosus	5.26e-05	0.000125	CcSEcCtD
Epirubicin—Fatigue—Methotrexate—systemic lupus erythematosus	5.25e-05	0.000125	CcSEcCtD
Epirubicin—Headache—Betamethasone—systemic lupus erythematosus	5.24e-05	0.000125	CcSEcCtD
Epirubicin—Headache—Dexamethasone—systemic lupus erythematosus	5.24e-05	0.000125	CcSEcCtD
Epirubicin—PLA2G4A—Hemostasis—F2—systemic lupus erythematosus	5.23e-05	0.000865	CbGpPWpGaD
Epirubicin—Asthenia—Prednisone—systemic lupus erythematosus	5.23e-05	0.000124	CcSEcCtD
Epirubicin—Pain—Methotrexate—systemic lupus erythematosus	5.21e-05	0.000124	CcSEcCtD
Epirubicin—DHCR7—Metabolism—ALB—systemic lupus erythematosus	5.2e-05	0.00086	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—CDKN1A—systemic lupus erythematosus	5.18e-05	0.000855	CbGpPWpGaD
Epirubicin—Pruritus—Prednisone—systemic lupus erythematosus	5.15e-05	0.000123	CcSEcCtD
Epirubicin—PLA2G4A—Signaling by GPCR—CXCL12—systemic lupus erythematosus	5.11e-05	0.000844	CbGpPWpGaD
Epirubicin—Feeling abnormal—Methotrexate—systemic lupus erythematosus	5.02e-05	0.000119	CcSEcCtD
Epirubicin—TOP2A—Circadian rythm related genes—IL6—systemic lupus erythematosus	5e-05	0.000827	CbGpPWpGaD
Epirubicin—Diarrhoea—Prednisone—systemic lupus erythematosus	4.98e-05	0.000119	CcSEcCtD
Epirubicin—DHCR7—Metabolism—NOS3—systemic lupus erythematosus	4.98e-05	0.000823	CbGpPWpGaD
Epirubicin—Gastrointestinal pain—Methotrexate—systemic lupus erythematosus	4.98e-05	0.000118	CcSEcCtD
Epirubicin—Nausea—Betamethasone—systemic lupus erythematosus	4.97e-05	0.000118	CcSEcCtD
Epirubicin—Nausea—Dexamethasone—systemic lupus erythematosus	4.97e-05	0.000118	CcSEcCtD
Epirubicin—YWHAG—Cell Cycle—EP300—systemic lupus erythematosus	4.92e-05	0.000814	CbGpPWpGaD
Epirubicin—Urticaria—Methotrexate—systemic lupus erythematosus	4.84e-05	0.000115	CcSEcCtD
Epirubicin—ABCC1—Disease—HIST2H2AC—systemic lupus erythematosus	4.83e-05	0.000798	CbGpPWpGaD
Epirubicin—Dizziness—Prednisone—systemic lupus erythematosus	4.82e-05	0.000115	CcSEcCtD
Epirubicin—Abdominal pain—Methotrexate—systemic lupus erythematosus	4.81e-05	0.000114	CcSEcCtD
Epirubicin—Body temperature increased—Methotrexate—systemic lupus erythematosus	4.81e-05	0.000114	CcSEcCtD
Epirubicin—PLA2G4A—Signaling by GPCR—RASGRP1—systemic lupus erythematosus	4.76e-05	0.000787	CbGpPWpGaD
Epirubicin—ABCC1—Disease—CSK—systemic lupus erythematosus	4.71e-05	0.000778	CbGpPWpGaD
Epirubicin—Vomiting—Prednisone—systemic lupus erythematosus	4.63e-05	0.00011	CcSEcCtD
Epirubicin—PLA2G4A—Signaling Pathways—TLR9—systemic lupus erythematosus	4.63e-05	0.000765	CbGpPWpGaD
Epirubicin—Rash—Prednisone—systemic lupus erythematosus	4.59e-05	0.000109	CcSEcCtD
Epirubicin—Dermatitis—Prednisone—systemic lupus erythematosus	4.59e-05	0.000109	CcSEcCtD
Epirubicin—Headache—Prednisone—systemic lupus erythematosus	4.56e-05	0.000109	CcSEcCtD
Epirubicin—DHCR7—Metabolism—PTGS2—systemic lupus erythematosus	4.55e-05	0.000752	CbGpPWpGaD
Epirubicin—Hypersensitivity—Methotrexate—systemic lupus erythematosus	4.48e-05	0.000107	CcSEcCtD
Epirubicin—PLA2G4A—Signaling Pathways—P2RY12—systemic lupus erythematosus	4.48e-05	0.000741	CbGpPWpGaD
Epirubicin—ABCC1—Disease—CD247—systemic lupus erythematosus	4.43e-05	0.000731	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—NAT2—systemic lupus erythematosus	4.42e-05	0.000731	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	4.4e-05	0.000727	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle, Mitotic—CDKN1B—systemic lupus erythematosus	4.39e-05	0.000725	CbGpPWpGaD
Epirubicin—Asthenia—Methotrexate—systemic lupus erythematosus	4.37e-05	0.000104	CcSEcCtD
Epirubicin—PLA2G4A—Hemostasis—ALB—systemic lupus erythematosus	4.34e-05	0.000718	CbGpPWpGaD
Epirubicin—Nausea—Prednisone—systemic lupus erythematosus	4.33e-05	0.000103	CcSEcCtD
Epirubicin—Pruritus—Methotrexate—systemic lupus erythematosus	4.31e-05	0.000102	CcSEcCtD
Epirubicin—ABCC1—Disease—NCF2—systemic lupus erythematosus	4.3e-05	0.000711	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	4.23e-05	0.0007	CbGpPWpGaD
Epirubicin—Diarrhoea—Methotrexate—systemic lupus erythematosus	4.16e-05	9.91e-05	CcSEcCtD
Epirubicin—PLA2G4A—Hemostasis—NOS3—systemic lupus erythematosus	4.16e-05	0.000687	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CSK—systemic lupus erythematosus	4.13e-05	0.000682	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle, Mitotic—CDKN1A—systemic lupus erythematosus	4.05e-05	0.000669	CbGpPWpGaD
Epirubicin—Dizziness—Methotrexate—systemic lupus erythematosus	4.03e-05	9.58e-05	CcSEcCtD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	3.96e-05	0.000654	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—CDKN1B—systemic lupus erythematosus	3.92e-05	0.000648	CbGpPWpGaD
Epirubicin—Vomiting—Methotrexate—systemic lupus erythematosus	3.87e-05	9.21e-05	CcSEcCtD
Epirubicin—TOP2A—Cell Cycle, Mitotic—EP300—systemic lupus erythematosus	3.85e-05	0.000637	CbGpPWpGaD
Epirubicin—Rash—Methotrexate—systemic lupus erythematosus	3.84e-05	9.13e-05	CcSEcCtD
Epirubicin—Dermatitis—Methotrexate—systemic lupus erythematosus	3.83e-05	9.12e-05	CcSEcCtD
Epirubicin—Headache—Methotrexate—systemic lupus erythematosus	3.81e-05	9.07e-05	CcSEcCtD
Epirubicin—DHCR7—Metabolism—EP300—systemic lupus erythematosus	3.79e-05	0.000626	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—NCF2—systemic lupus erythematosus	3.77e-05	0.000624	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—LYN—systemic lupus erythematosus	3.75e-05	0.000619	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—JAK1—systemic lupus erythematosus	3.69e-05	0.00061	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—SH2B3—systemic lupus erythematosus	3.68e-05	0.000608	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—CDKN1A—systemic lupus erythematosus	3.62e-05	0.000598	CbGpPWpGaD
Epirubicin—Nausea—Methotrexate—systemic lupus erythematosus	3.62e-05	8.6e-05	CcSEcCtD
Epirubicin—PLA2G4A—Hemostasis—IL2—systemic lupus erythematosus	3.52e-05	0.000582	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	3.51e-05	0.000581	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—CCR5—systemic lupus erythematosus	3.5e-05	0.000578	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	3.46e-05	0.000572	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—IL2RA—systemic lupus erythematosus	3.45e-05	0.00057	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—EP300—systemic lupus erythematosus	3.44e-05	0.000569	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—C3—systemic lupus erythematosus	3.42e-05	0.000565	CbGpPWpGaD
Epirubicin—ABCC1—Disease—JUNB—systemic lupus erythematosus	3.38e-05	0.000558	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—RXRA—systemic lupus erythematosus	3.16e-05	0.000523	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—EP300—systemic lupus erythematosus	3.16e-05	0.000522	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	3.16e-05	0.000522	CbGpPWpGaD
Epirubicin—ABCC1—Disease—PRL—systemic lupus erythematosus	3.11e-05	0.000514	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—RXRA—systemic lupus erythematosus	3.1e-05	0.000513	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CXCL12—systemic lupus erythematosus	3.02e-05	0.000498	CbGpPWpGaD
Epirubicin—ABCC1—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	3.01e-05	0.000497	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—F2—systemic lupus erythematosus	3e-05	0.000496	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—VEGFA—systemic lupus erythematosus	2.99e-05	0.000495	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—JUNB—systemic lupus erythematosus	2.96e-05	0.000489	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	2.88e-05	0.000476	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—RASGRP1—systemic lupus erythematosus	2.81e-05	0.000465	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	2.76e-05	0.000457	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—TGFB1—systemic lupus erythematosus	2.75e-05	0.000454	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—PRL—systemic lupus erythematosus	2.73e-05	0.000451	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—CCL2—systemic lupus erythematosus	2.68e-05	0.000442	CbGpPWpGaD
Epirubicin—ABCC1—Disease—JAK1—systemic lupus erythematosus	2.49e-05	0.000411	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—RXRA—systemic lupus erythematosus	2.48e-05	0.00041	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—TYK2—systemic lupus erythematosus	2.43e-05	0.000402	CbGpPWpGaD
Epirubicin—ABCC1—Disease—CCR5—systemic lupus erythematosus	2.36e-05	0.00039	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	2.3e-05	0.00038	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—JAK1—systemic lupus erythematosus	2.18e-05	0.000361	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CCR5—systemic lupus erythematosus	2.07e-05	0.000342	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—IL2RA—systemic lupus erythematosus	2.04e-05	0.000337	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—IL2—systemic lupus erythematosus	2.02e-05	0.000334	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—C3—systemic lupus erythematosus	2.02e-05	0.000334	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—PPARG—systemic lupus erythematosus	2e-05	0.00033	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—PPARG—systemic lupus erythematosus	1.96e-05	0.000324	CbGpPWpGaD
Epirubicin—ABCC1—Disease—CD80—systemic lupus erythematosus	1.94e-05	0.000321	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—ALB—systemic lupus erythematosus	1.8e-05	0.000297	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—F2—systemic lupus erythematosus	1.77e-05	0.000293	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—ALB—systemic lupus erythematosus	1.76e-05	0.000291	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—NOS3—systemic lupus erythematosus	1.72e-05	0.000284	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CD80—systemic lupus erythematosus	1.7e-05	0.000281	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—NOS3—systemic lupus erythematosus	1.68e-05	0.000278	CbGpPWpGaD
Epirubicin—ABCC1—Disease—TYK2—systemic lupus erythematosus	1.64e-05	0.000271	CbGpPWpGaD
Epirubicin—ABCC1—Disease—NOS3—systemic lupus erythematosus	1.61e-05	0.000266	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CCL2—systemic lupus erythematosus	1.58e-05	0.000261	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—PTGS2—systemic lupus erythematosus	1.57e-05	0.00026	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—PPARG—systemic lupus erythematosus	1.57e-05	0.000259	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—PTGS2—systemic lupus erythematosus	1.54e-05	0.000255	CbGpPWpGaD
Epirubicin—ABCC1—Disease—CD4—systemic lupus erythematosus	1.48e-05	0.000245	CbGpPWpGaD
Epirubicin—ABCC1—Disease—PTGS2—systemic lupus erythematosus	1.47e-05	0.000243	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—TYK2—systemic lupus erythematosus	1.44e-05	0.000237	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—NOS3—systemic lupus erythematosus	1.41e-05	0.000233	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—ALB—systemic lupus erythematosus	1.41e-05	0.000233	CbGpPWpGaD
Epirubicin—ABCC1—Disease—CDKN1B—systemic lupus erythematosus	1.39e-05	0.00023	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—NOS3—systemic lupus erythematosus	1.35e-05	0.000223	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—EP300—systemic lupus erythematosus	1.31e-05	0.000216	CbGpPWpGaD
Epirubicin—ABCC1—Disease—CDKN1A—systemic lupus erythematosus	1.29e-05	0.000212	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—EP300—systemic lupus erythematosus	1.28e-05	0.000212	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—PTGS2—systemic lupus erythematosus	1.23e-05	0.000204	CbGpPWpGaD
Epirubicin—ABCC1—Disease—EP300—systemic lupus erythematosus	1.22e-05	0.000202	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.22e-05	0.000202	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—IL2—systemic lupus erythematosus	1.19e-05	0.000197	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—IL6—systemic lupus erythematosus	1.19e-05	0.000196	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—MMP9—systemic lupus erythematosus	1.13e-05	0.000187	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.13e-05	0.000186	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—EP300—systemic lupus erythematosus	1.07e-05	0.000177	CbGpPWpGaD
Epirubicin—ABCC1—Disease—TGFB1—systemic lupus erythematosus	1.06e-05	0.000176	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—EP300—systemic lupus erythematosus	1.02e-05	0.000169	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.02e-05	0.000168	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—TGFB1—systemic lupus erythematosus	9.32e-06	0.000154	CbGpPWpGaD
Epirubicin—ABCC1—Disease—IL6—systemic lupus erythematosus	8.01e-06	0.000132	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—IL6—systemic lupus erythematosus	7.02e-06	0.000116	CbGpPWpGaD
